packageAnagrelide

anagrelide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Anagrelide is used to treat essential thrombocythemia, a condition in which the body makes too many platelets. It is authorised in the European Union and remains in clinical use.

Summary written by glm-5.3-flash from Wikidata Q408163 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:anagrelide
ATC codes:L01XX35
DrugBank:DB00261
PubChem CID:2182
ChEBI:142290
Wikidata:Q408163
formula:C10H7Cl2N3O
molar mass:256.088 g/mol (knowledgebase (DrugBank calculated))
logP:1.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown